Nicholas A. Labella Jr.
Chief Scientific Officer, INSMED Inc.
Companies
- ZyVersa Therapeutics, Inc.Chief Scientific Officer Dec 13, 2022 to Dec 14, 20221
- INSMED IncChief Scientific Officer Mar 23, 2010 to Dec 23, 20112
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- ZyVersa Therapeutics, Inc. ZVSA18,094 shares3$869 at $0.05Dec 12, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Dec 12, 2022Granted 18,094 shares of ZyVersa Therapeutics, Inc.3
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARINSMED Inc, Chief Scientific Officer
- 3